Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded promising discoveries into new therapeutic approaches. Current efforts centers on targeting the underlying mechanisms of MSA. One approach under investigation involves pharmacological interventions to influence the dysregulation of